We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a ...

Shares of Charles River Laboratories International Inc. CRL rose 1.73% to $106.05 Thursday, on what proved to be an ...

Baird analyst Eric Coldwell raised the firm’s price target on Charles River (CRL) to $118 from $101 and keeps a Neutral rating on the shares.

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Raja Chatterjee has joined the Company's Risk, ...

The S&P 500 gained 0.8% on Monday, April 14, 2025, after smartphones and other electronics were exempted from President ...

The Alamogordo chimpanzees, many in their 50s and 60s, were the last remaining at the facility due to their age and fragility ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...

Charles River Labs faces a 60% loss due to reduced R&D spending, FDA's phase-out of animal testing, and increased competition ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

The stock has an above average percentage of its shares sold short at 8.4%, and a short ratio of 2.17. Only 0.88% of the ...

FDA introduces a new roadmap to reduce animal testing in monoclonal antibody development using AI models, organoid testing and real-world data to enhance safety and efficiency.